Related Experiment Video
Updated: Jul 17, 2026

A Human Fallopian Tube Model for Investigation of C. trachomatis Infections
Published on: August 11, 2012
Trachoma: ancient scourge, disease elimination, and future research
1Clinical Research and Development, Pfizer Inc., and College of Physicians and Surgeons, Columbia University, 685 3rd Avenue, New York, NY 10017, USA. charles.knirsch@pfizer.com
Abstract:
Realistically, global elimination of trachoma could not have been considered until the maturation of innovation and public will that converged with the formation of both the Alliance for the Global Elimination of Trachoma by the year 2020 (GET2020) in 1997 and the public-private partnership, the International Trachoma Initiative (ITI) in 1998. Public-private partnerships are cross-sector collaborations that bring heterogeneous capabilities together to work on difficult problems for which the individual partners share common goals. The work of the ITI and partners to date demonstrates that the SAFE strategy reviewed in this article can work, and that it will revolutionize the control of blinding trachoma. Programs working to eliminate trachoma can achieve the GET2020 goals through expanded partnerships, commitment, and research on program integration into evolving health systems.
Related Concept Videos
Trichomoniasis
American Trypanosomiasis
Antiprotozoal Agents
Microbiome of the Eye
Acne Infection
